-
Indonesia's first giant panda is set to charm the public
-
Cheer and tears as African refugee rap film 'Congo Boy' charms Cannes
-
Norwegian Ruud rolls into Italian Open final, Sinner set for Medvedev clash
-
Bolivia government says deal reached with protesting miners
-
Showdowns and spycraft on Trump-Xi summit sidelines
-
Smalley seizes PGA lead with Matsuyama making a charge
-
Acosta quickest in practice for Catalan MotoGP
-
Nuno wants VAR 'consistency' as West Ham fight to avoid relegation
-
Vingegaard powers to maiden Giro stage victory
-
Iran to hold pre-World Cup training camp in Turkey: media
-
US scraps deployment of 4,000 troops to Poland
-
Ukraine vows more strikes on Russia after attack on Kyiv kills 24
-
Bayern veteran Neuer signs one-year contract extension
-
Ukraine can down Russian drones en masse. But missiles are a problem
-
Israeli strikes wound dozens in Lebanon as talks in US enter second day
-
'Everybody wants Hearts to win', says Celtic's O'Neill ahead of title decider
-
Scheffler stumbles from share of lead at windy PGA
-
New deadly Ebola outbreak hits DR Congo
-
Farke calls for Leeds owners to match his ambition
-
Zverev pulls out of home event in Hamburg with back injury
-
Xi, Trump eke small wins from talks but no major deals: analysts
-
De Ligt to miss World Cup after back surgery
-
England's Rice braces for 'hate and love' at World Cup
-
Milan Fashion Week says will ask brands not to show fur
-
French-German tank maker KNDS to push ahead with IPO
-
Man City campaign a success regardless of trophies: Guardiola
-
'World's oldest dog' contender dies in France aged 30
-
No.1 Scheffler opens with bogey to fall from share of PGA lead
-
Carrick says Man Utd future to be decided 'pretty soon'
-
'Out of shape' Lukaku named in Belgium World Cup squad
-
Hearts ready to 'rip up the script' in Celtic title showdown
-
X pledges crackdown on illegal content in UK
-
Possible contenders in UK Labour Party leadership race
-
Germany's Merz says wouldn't advise young people to move to US
-
Israel strikes Lebanon as talks in US enter second day
-
Kyiv in mourning after 24 killed as Ukraine, Russia swap POWs
-
Beckham becomes first British billionaire sportsman
-
Aussie star, Danish clubbing ode through to Eurovision final
-
German Oscar winner Huller feels war guilt 'every day'
-
Thai lawmakers vote to revive clean air bill
-
Bayern warn that Canada's Davies struggling to be fit for World Cup
-
Long-serving Coleman to end Everton career at end of season
-
Energy-hungry German industries in decline since Ukraine war: data
-
Gordon may have made last Newcastle appearance: Howe
-
Denmark's Queen Margrethe has angioplasty in hospital: palace
-
Civilians caught in war of drones in eastern DR Congo
-
French city reels from teen killing in drug-linked shooting
-
NZ passenger from hantavirus cruise quarantines in Taiwan
-
Sci-fi or battlefield reality? Ukraine's bet on drone swarms
-
Russia, Ukraine swap 205 prisoners of war each
The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
L.Dubois--BTB